Emerging drugs for polycythemia vera. (Record no. 23025887)

MARC details
000 -LEADER
fixed length control field 01053 a2200277 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516164927.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201403s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1744-7623
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1517/14728214.2013.832754
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Tibes, Raoul
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20140303
245 00 - TITLE STATEMENT
Title Emerging drugs for polycythemia vera.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Expert opinion on emerging drugs
Date of publication, distribution, etc. Sep 2013
300 ## - PHYSICAL DESCRIPTION
Extent 393-404 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hydroxyurea
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon-alpha
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Janus Kinase 2
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polycythemia Vera
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mesa, Ruben A
773 0# - HOST ITEM ENTRY
Title Expert opinion on emerging drugs
Related parts vol. 18
-- no. 3
-- p. 393-404
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1517/14728214.2013.832754">https://doi.org/10.1517/14728214.2013.832754</a>
Public note Available from publisher's website

No items available.